Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study.

Clin Transl Oncol · 2022 · PMC9283188 · PMID 35364771

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Therefore, the expression of FANCG in the FA-BRCA pathway showed a trend of steady decline after the combination of niraparib tosylate and radiotherapy.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.